
Loading, please wait...

Loading, please wait...

Needle-related distress in dialysis represents a significant clinical hurdle for nephrology teams and patients worldwide. Although haemodialysis is a life-sustaining treatment, the requirement for frequent large-bore needle insertions often leads to substantial psychological burden. Consequently, many patients suffer in silence, which can ultimately impact their adherence to treatment and overall quality of life.
A recent pilot study, termed the INJECT study, evaluated a novel intervention to address this issue. The programme combined psychologist evaluations, self-managed online cognitive behavioural therapy (CBT), and comprehensive nursing education. Researchers aimed to determine if this multi-pronged approach could effectively reduce the fear and anxiety associated with vascular access cannulation in a tertiary renal unit.
The study faced several implementation barriers that hindered the progression to a full clinical trial. Specifically, recruitment proved difficult as only 18 out of 39 referred patients consented to the intervention. The COVID-19 pandemic significantly disrupted patient outreach and engagement during the study period. Furthermore, researchers noted a clear discrepancy between the distress patients reported and what nurses observed during treatment.
Moreover, the inherent disease and treatment burden of end-stage kidney disease made sustaining engagement with an online CBT programme difficult. Many patients struggled to find the time or energy to complete the modules while managing their complex health needs. Therefore, while those who completed the programme found it useful, the overall attrition rate remained high.
In contrast to the challenges faced with patient-led CBT, the nursing education component of the study was highly successful. A total of 133 dialysis nurses completed the training programme. This education focused on recognising needle fear and implementing best-practice cannulation techniques. Consequently, nurses reported significant improvements in their knowledge and confidence regarding the management of needle-related distress in dialysis.
This finding suggests that while self-managed psychological interventions may be difficult for patients to navigate alone, empowering the clinical staff provides a more sustainable path forward. Integrating psychological support into routine nursing care can create a more empathetic and supportive environment. This shift may help de-escalate patient anxiety before it becomes a barrier to life-saving care.
Ultimately, the pilot study concluded that a purely self-managed CBT model is currently unsuitable for large-scale clinical trials in this population. However, the success of the nurse education module highlights an alternative strategy. Future interventions should perhaps focus on staff-led support and integrated psychological screening rather than relying solely on patient-led digital tools.
There is often a discrepancy between a patient's internal experience and the external signs observed by clinicians. Many patients learn to tolerate distress as an inevitable part of survival, while busy clinical environments may focus more on technical success than psychological comfort.
The study indicated that for the small group of patients who completed the modules, needle-related distress was reduced. However, high treatment burden makes it difficult for most dialysis patients to maintain long-term engagement with self-managed digital programmes.
Education helps nurses identify subtle signs of anxiety and provides them with communication tools to support patients. Improved technical confidence and empathy from the nursing staff can significantly lower the patient's perceived stress during the cannulation process.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider regarding any medical condition or treatment. Refer to the latest local and national guidelines for clinical practice.
References
Radisic G et al. Process evaluation of a pilot study of a self-managed, online cognitive behavioural therapy programme to address needle-related distress in haemodialysis recipients. J Vasc Access. 2026 May 05. doi: 10.1177/11297298261437914. PMID: 42083932.
Richmond H, et al. Cognitive behavioural therapy for needle phobia in chronic disease management: A systematic review. Journal of Psychosomatic Research. 2020.
Duncanson E, et al. The prevalence and impact of needle-related distress in patients receiving maintenance haemodialysis. PLOS ONE. 2020.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A pilot study evaluating a self-managed online CBT program for needle-related distress in dialysis patients highlights significant implementation barriers....
5 months ago

Explore vital recurrent stroke predictors in lacunar stroke patients managed with intensive blood pressure lowering. This analysis examines trial findings from SPS3 to uncover residual vascular risks, metabolic factors, and targeted secondary prevention strategies for high-risk neurological patients.
Today

Odisha has established India's first state-level clinical protocol specifically tailored for pregnant women with sickle cell disease. Developed with NHM and UNICEF, the framework provides structured antenatal screening, crisis mitigation, standardized referral pathways, and specialized interdisciplinary care.
Today

The Directorate General of Health Services directs Indian states to halt the hazardous reuse and reprocessing of single-use medical devices. Discover regulatory implications under the Drugs and Cosmetics Act, critical infection risks, legal liabilities, and operational changes required across clinical specialties.
Today

Mitochondria-targeted nanoparticles self-assembled from EGCG and L-glutamic acid effectively restore mitochondrial homeostasis, suppress synovial inflammation, and attenuate chondrocyte senescence in osteoarthritis, offering a promising disease-modifying nanotherapy.
Today

India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today